* Pharvaris BV PHVS.OQ reported a quarterly adjusted loss of
$2.64 per share for the quarter ended in December. The mean
expectation of three analysts for the quarter was for a loss of
$1.38 per share.
* Revenue was $0.00; analysts expected $0.00.
* Pharvaris BV's reported EPS for the quarter was a loss of
$2.64.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Pharvaris BV shares had fallen by 11.2% this quarter.
* The company reported a quarterly loss of $12.8 million.
* Wall Street's median 12-month price target for Pharvaris BV is
$48.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated April 30 at 08:44 a.m. GMT.
All figures in US Dollars.